Inventor
KANNER STEVEN B
US35 patents
⚠️ This page may combine multiple inventors who share the name “KANNER STEVEN B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
11 patentsUS6706717B2Mar 16, 2004
Thiazolyl inhibitors of Tec family tyrosine kinases
BRISTOL MYERS SQUIBB CO73 citations98
US7241781B2Jul 10, 2007
Thiazolyl inhibitors of Tec family tyrosine kinases
BRISTOL MYERS SQUIBB CO17 citations92
US7037926B2May 2, 2006
Thiazolyl inhibitors of Tec family tyrosine kinases
BRISTOL MYERS SQUIBB CO1 citations63
US6958336B2Oct 25, 2005
Thiazolyl inhibitors of Tec family tyrosine kinases
BRISTOL MYERS SQUIBB CO2 citations63
US6956045B2Oct 18, 2005
Thiazolyl inhibitors of Tec family tyrosine kinases
BRISTOL MYERS SQUIBB CO2 citations63
US6953795B2Oct 11, 2005
Thiazolyl inhibitors of Tec family tyrosine kinases
BRISTOL MYERS SQUIBB CO2 citations63
US7101686B1Sep 5, 2006
Polynucleotides encoding human SLAP-2:a novel SH2/SH3 domain-containing human SLAP homologue having immune cell-specific expression
BRISTOL MYERS SQUIBB CO2 citations61
US7667003B2Feb 23, 2010
Antibody directed to human mist (mast cell immunoreceptor signal transducer)
BRISTOL MYERS SQUIBB CO0 citations51
US7517957B2Apr 14, 2009
Human SLAP-2: a novel SH2/ SH3 domain-containing human SLAP homologue having immune cell-specific expression
BRISTOL MYERS SQUIBB CO0 citations51
US7442770B2Oct 28, 2008
Human clnk-related polypeptide, MIST (Mast Cell Immunoreceptor Signal Transducer)
BRISTOL MYERS SQUIBB CO0 citations51
US7241590B2Jul 10, 2007
Identification and cloning of a full-length human Clnk-related gene, MIST (mast cell immunoreceptor signal transducer)
BRISTOL MYERS SQUIBB CO0 citations51
AGENSYS INC
11 patentsUS7811565B2Oct 12, 2010
Antibodies and related molecules that bind to 161P2F10B proteins
AGENSYS INC20 citations92
US7427399B2Sep 23, 2008
Antibodies and related molecules that bind to 161P2F10B proteins
AGENSYS INC21 citations92
US8350009B2Jan 8, 2013
Antibodies and related molecules that bind to 161P2F10B proteins
AGENSYS INC6 citations84
US8039597B2Oct 18, 2011
Antibodies and related molecules that bind to 24P4C12 proteins
AGENSYS INC11 citations84
US7358353B2Apr 15, 2008
Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
AGENSYS INC7 citations74
US8945570B2Feb 3, 2015
Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
AGENSYS INC1 citations63
US7842458B2Nov 30, 2010
Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
AGENSYS INC2 citations63
US7811575B2Oct 12, 2010
Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer
AGENSYS INC2 citations63
US7638270B2Dec 29, 2009
Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
AGENSYS INC1 citations63
US8951744B2Feb 10, 2015
Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
AGENSYS INC0 citations52
US7927597B2Apr 19, 2011
Methods to inhibit cell growth
AGENSYS INC1 citations52
ARROWHEAD PHARMACEUTICALS INC
6 patentsUS12188017B2Jan 7, 2025
Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin
ARROWHEAD PHARMACEUTICALS INC1 citations73
US10308941B2Jun 4, 2019
Compositions and methods for inhibiting gene expression of factor XII
ARROWHEAD PHARMACEUTICALS INC4 citations73
US11384355B2Jul 12, 2022
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
ARROWHEAD PHARMACEUTICALS INC3 citations72
US10927373B2Feb 23, 2021
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD PHARMACEUTICALS INC2 citations71
US11840688B2Dec 12, 2023
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD PHARMACEUTICALS INC0 citations61
US10858658B2Dec 8, 2020
Compositions and methods for inhibiting gene expression of factor XII
ARROWHEAD PHARMACEUTICALS INC0 citations52
ARROWHEAD MADISON INC
3 patentsUS9803205B2Oct 31, 2017
Compositions and methods for inhibiting gene expression of factor XII
ARROWHEAD MADISON INC9 citations83
US10006025B2Jun 26, 2018
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
ARROWHEAD MADISON INC5 citations82
US9976141B2May 22, 2018
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD MADISON INC5 citations82
RAITANO ARTHUR B
3 patentsUS8524872B2Sep 3, 2013
Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer
RAITANO ARTHUR B0 citations52
US8460881B2Jun 11, 2013
Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
RAITANO ARTHUR B0 citations52
US8212017B2Jul 3, 2012
Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer
RAITANO ARTHUR B0 citations52